James Duffy

James Duffy is a Senior Director of Drug Discovery at Medicines for Malaria Venture (MMV) with 25 years’ experience working in drug discovery. He has a special interest in malaria and other infectious diseases that disproportionately affect vulnerable populations in the global south. Working at MMV, he is part of the efforts to reduce the burden of malaria in disease-endemic countries by discovering, developing and delivering new, effective and affordable antimalarial drugs. His current role is to provide scientific input and strategic leadership to multidisciplinary collaborations with academic, biotechnology and pharmaceutical partners engaged in malaria drug discovery projects. He obtained his PhD from the University of Sussex (Brighton, UK) and prior to MMV worked at BioFocus (Cambridge, UK) where he was a co-inventor of the FDA approved HDAC inhibitor Belinostat.